Epidemiology: Identifying Cancer's Causes

The Biology and Treatment of Cancer: Understanding Cancer

Volumn , Issue , 2008, Pages 223-255

  Hebert, James R ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Epidemiology identifying cancer causes; Epidemiology and identifying predisposing genetic factors; Problem of type III error and gene environment interactions

Indexed keywords

EID: 84891000109     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470374252.ch13     Document Type: Chapter

References (94)

1. Last JM, ed. 2001. A Dictionary of Epidemiology, 4th ed. New York: Oxford University Press.
2. Spiegel D, Bloom J, Kraemer H, Gotheil E. 1989. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891.
3. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. 1995. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52:100-113.
4. Hebert JR, Kabat GC. 1991. Distribution of smoking and its association with lung cancer: implication for fat-cancer studies. J Natl Cancer Inst 83:872-874.
5. Hebert JR. 2005. Epidemiologic studies of diet and cancer: the case for international collaboration. Austro-Asian J Cancer 4(3):125-134.
6. Armstrong B, Doll R. 1975. Environmental factors and cancer incidence and mortality in different countries with special references to dietary practices. Int J Cancer 15:617-631.
7. Hebert JR, Hurley TG, Olendzki B, Ma Y, Teas J, Hampl JS. 1998. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 90:1637-1647.
8. Wynder EL, Hebert JR, Kabat GC. 1987. Association of dietary fat and lung cancer. J Natl Cancer Inst 79:631-637.
9. Haenszel W, Kurihara M. 1968. Studies of Japanese migrants: I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43-68.
10. Hebert JR, Miller DR. 1988. Methodologic considerations for investigating the diet-cancer link. Am J Clin Nutr 47:1068-1077.
11. Hebert JR, Ebbeling CB, Matthews CE, Ma Y, Clemow L, Hurley TG, Druker S. 2002. Systematic errors inmiddle-agedwomen's estimates of energy intake: comparing three self-report measures to total energy expenditure from doubly labeled water. Ann Epidemiol 12:577-586.
12. Doll R, Peto R. 1981. Avoidable risks of cancer in the U.S. J Natl Cancer Inst 66(6):1191-1308.
13. American Institute for Cancer Research. 1997. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR.
14. U.S. Department of Health and Human Services. 2006. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General-Executive Secretary. Atlanta, GA: USDHHS.
15. Saxe GA, Hebert JR, Carmody JF, Kabat-Zinn J, Rosenzweig PH, Jarzobski D, Reed GW, Blute RD. 2001. Can diet, in conjunction with stress reduction, affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? J Urol 166:2202-2207.
16. Cohen S, Rabin BS. 1998. Psychologic stress, immunity, and cancer. J Natl Cancer Inst 1:314.
17. Bovbjerg DH. 1991. Psychoneuroimmunology and psycho-oncology. Presented at Current Concepts in Psycho-Oncology IV, Oct. 10-12, 1991, Memorial Sloan-Kettering Cancer Center, New York.
18. Cooper CL, Faragher EB. 1993. Psychosocial stress and breast cancer: the inter-relationship between stress events, coping strategies and personality. Psychol Med 23(3):653-662.
19. Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. 2003. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control 14(8):761-766.
20. Schoenborn CA, Adams PF, Barnes PM, Vickerie JL, Schiller JS. 2004. Health behaviors of adults: United States, 1999-2001. Vital Health Stat 10(219):1-79.
21. Marmot MG. 2006. Status syndrome: a challenge to medicine. JAMA 295(11):1304-1307.
22. Hebert JR, Elder K, Ureda JR. 2006. Meeting the challenges of cancer prevention and control in South Carolina: focus on seven cancer sites, engaging partners. J SC Med Assoc 102:177-182.
23. Hrushesky WJ. 2000. The temporal organization of life: the impact of multi-frequency non-linear biologic time structure upon the host-cancer balance. Jpn J Clin Oncol 30(12):529-533.
24. You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. 2005. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat 91(1):47-60.
25. Hrushesky WJ, Bjarnason GA. 1993. Circadian cancer therapy. J Clin Oncol 11(7):1403-1417.
26. Wood PA, Hrushesky WJ. 1996. Circadian rhythms and cancer chemotherapy. Crit Rev Eukaryot Gene Expr 6(4):299-343.
27. Jones LA, Chilton JA, Hajek RA, Iammarino NK, Laufman L. 2006. Between and within: international perspectives on cancer and health disparities. J Clin Oncol 24(14):2204-2208.
28. Parkin DM. 1989. Cancers of the breast, endometrium and ovary: geographic correlations. Eur J Cancer Clin Oncol 25(12):1917-1925.
29. Hill AB. 1953. Observation and experiment. N Engl J Med 248:3-9.
30. U.S. Department of Health Education and Welfare. 1964. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Services. P.H.S. Publ. 1103. Washington, DC: USDHEW.
31. Boyle P, Kevi R, Lucchini F, La Vecchia C. 1993. Trends in diet-related cancers in Japan: a conundrum? Lancet 349:752.
32. Wynder E, Fujita Y, Harris R, Hirayama T, Hiyama T. 1991. Comparative epidemiology of cancer between the United States and Japan: a second look. Cancer 67:746-763.
33. Tajima D, Tominaga S. 1985. Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res (Gann) 76:705-716.
34. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. 2005. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomized controlled trial. Lancet 365(9475):1927-1933.
35. Yen KL, Horner MJD, Reed SG, Daguise VG, Johnson MG, Day TA, Wood PA, Hebert JR. 2006. Head and neck cancer disparities in South Carolina: descriptive epidemiology, early detection, and special programs. J SC Med Assoc 102:192-200.
36. Cattaruzza MS, Maisonneuve P, Boyle P. 1996. Epidemiology of laryngeal cancer. Eur J Cancer Part B Oral Oncol 32B(5):293-305.
37. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, Brasure J, Merletti F, Boyle P. 1995. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer Part B Oral Oncol 31B(3):181-187.
38. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF, Jr. 1998. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48(11):3282-3287.
39. Franceschi S, Talamini R, Barra S, Baron AE, Negri E, Bidoli E, Serraino D, La Vecchia C. 1990. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50(20):6502-6507.
40. Hebert JR, Kabat GC. 1988. Menthol cigarette smoking and esophageal cancer. Am J Public Health 78:986-987.
41. Hebert JR, Kabat GC. 1989. Menthol cigarette smoking and oesophageal cancer: results of a case-control study. Int J Epidemiol 18:37-44.
42. Chalasani N, Wo JM, Waring JP. 1998. Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol 26(1):11-13.
43. Nguyen AM, Luke CG, Roder D. 2003. Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia. Asian Pac J Cancer Prev 4(3):225-231.
44. U.S. Cancer Statistics Working Group. 2005. United States Cancer Statistics: 2002 Incidence and Mortality. Atlanta, GA: US DHHS/CDC/NIH-NCI.
45. National Cancer Institute. 2004. SEER Cancer Statistics Review, 1975-2001. Bethesda, MD: NCI. (Accessed January 4, 2005, at http://seer.cancer.gov/csr/1975_2001/).
46. South Carolina Central Cancer Registry Incidence (finalmast2005-statfile) and Mortality (cancermortality9404-statfile). 2006. Office of Public Health Statistics and Information Services, Department of Health and Environmental Control.
47. Stoner GD, Gupta A. 2001. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22(11):1737-1746.
48. Ahsan H, Neugut AI, Gammon MD. 1997. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomark Prev 6(10):779-782.
49. Lagergren J, Bergstrom R, Nyren O. 1999. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130(11):883-890.
50. Pera M. 2001. Recent changes in the epidemiology of esophageal cancer. Surg Oncol 10(3):81-90.
51. Shaheen NJ. 2005. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 128(6):1554-1566.
52. Coggon D, Barker DJ, Cole RB, Nelson M. 1989. Stomach cancer and food storage. J Natl Cancer Inst 81(15):1178-1182.
53. Crew KD, Neugut AI. 2006. Epidemiology of gastric cancer. World J Gastroenterol 12(3):354-362.
54. Ashktorab H, Smoot DT, Farzanmehr H, Fidelia-Lambert M, Momen B, Hylind L, Iacosozio-Dononue C, Carethers JM, Goel A, Boland CR, Giardiello FM. 2005. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer 116(6):914-919.
55. Krzystyniak KL. 2002. Current strategies for anticancer chemoprevention and chemoprotection. Acta Pol Pharm 59(6):473-478.
56. Vena JE, Graham S, Zielezny M, Swanson MK, Barnes RE, Nolan J. 1985. Lifetime occupational exercise and colon cancer. Am J Epidemiol 122(3):357-365.
57. American Cancer Society. 2006. Cancer Facts and Figures 2005. Atlanta, GA: ACS.
58. Levin B. 1992. Inflammatory bowel disease and colon cancer. Cancer 70(5 Suppl):1313-1316.
59. Rhodes JM, Campbell BJ. 2002. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8(1):10-16.
60. Sherman M. 2005. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 25(2):143-154.
61. Lowenfels AB, Maisonneuve P. 2006. Epidemiology and risk factors for pancreatic cancer. Best Pract Re Clin Gastroenterol 20(2):197-209.
62. U.S. Department of Health and Human Services. 2004. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta, GA: Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
63. U.S. Department of Health and Human Services. 1990. CH2, Assessing smoking cessation and its health consequences. The Health Benefits of Smoking Cessation: A report of the Surgeon General. DHHS Publication (CDC) 90-8416. Atlanta, GA: Centers for Disease Control, Office on Smoking and Health.
64. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. 2005. Cancer Statistics Review 1975-2002. Bethesda, MD: National Cancer Institute.
65. Alberg AJ, Samet JM. 2003. Epidemiology of lung cancer. Chest 123(1 Suppl):21S-49S.
66. Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP. 2005. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 103(7):1420-1426.
67. Geller AC, Annas GD. 2003. Epidemiology of melanoma and nonmelanoma skin cancer. Sem Oncol Nurs 19(1):2-11.
68. Hebert JR, Rosen A. 1996. Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. Cancer Detect Prevent 20:234-244.
69. Buell P. 1973. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479-1483.
70. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. 1995. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87(22):1681-1685.
71. Adams SA, Hebert JR, Bolick-Aldrich S, Daguise VG, Mosley CM, Modayil MV, Berger SH, Teas J, Mitas M, Cunningham JE, Steck SE, Burch J, Butler WM, Horner MJD, Brandt HM. 2006. Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. JSC Med Assoc 102:231-239.
72. Cox JT. 2006. The development of cervical cancer and its precursors: What is the role of human papillomavirus infection? Curr Opin Obstet Gynecol 18 (Suppl 1):s5-s13.
73. Purdie DM, Green AC. 2001. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 15(3):341-354.
74. Morrison J. 2005. Advances in the understanding and treatment of ovarian cancer. J Br Menopause Soc 11(2):66-71.
75. Lukanova, Kaaks R. 2005. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomark Prev 14(1):98-107.
76. Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P. 1982. Geographic pathology of latent prostatic carcinoma. Int J Cancer 29(6):611-616.
77. Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR. 2006. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. JSC Med Assoc 102:241-249.
78. Schmid H-P, Riesen W, Prikler L. 2004. Update on screening for prostate cancer with prostatespecific antigen. Crit Rev Oncol Hematol 50(1):71-78.
79. Sorun PC, Shim J, Chasseigne G, Bonnin-Scaon S, Cogneau J, Mullet E. 2003. Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients? Med Decision Making 23:301-313.
80. Shimuzu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. 1991. Cancers of the prostate and breast among Japanese and white immigrants to Los Angeles County. Br J Cancer 63:963-966.
81. Mettlin C, Selenskas S, Natarajan N, Huben R. 1989. Beta-carotene and animal fats and their relationship to prostate cancer risk: a case-control study. Cancer 64:605-612.
82. Carroll KK, Noble RC. 1987. Dietary fat in relation to hormonal induction of mammary and prostate carcinoma in Nb rats. Carcinogenesis 81:851-853.
83. Friedenreich CM. 2001. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomark Prev 10:287-301.
84. Baillargeon J, Rose DP. 2006. Obesity, adipokines, and prostate cancer. Int J Oncol 28(3):737-745.
85. Garner MJ, Turner MC, Ghadirian P, Krewski D. 2005. Epidemiology of testicular cancer: an overview. Int J Cancer 116(3):331-339.
86. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. 2006. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3(6):327-340.
87. Albanes D. 1987. Caloric intake, body weight, and cancer: a review. Nutr Cancer 9(4):199-217.
88. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K. 2002. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94(20):1555-1563.
89. Johnson CC, Spitz MR. 1989. Childhood nervous system tumours: an assessment of risk associated with paternal occupations involving use, repair or manufacture of electrical and electronic equipment. Int J Epidemiol 18(4):756-762.
90. Muir CS, Storm HH, Polednak A. 1994. Brain and other nervous system tumours. Cancer Surveys 19-20:369-392.
91. Nagataki S, Nystrom E. 2002. Epidemiology and primary prevention of thyroid cancer. Thyroid 12(10):889-896.
92. Swerdlow AJ. 2003. Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nuclear Med Mol Imag 30 (Suppl 1):S3-12.
93. Rinsky RA, Smith AB, Hornung R, Filloon TG, Young RJ, Okun AH, Landrigan PJ. 1987. Benzene and leukemia: an epidemiologic risk assessment. N Engl J Med 316(17):1044-1050.
94. Viswanathan M, Ammerman A, Eng E, Gartlehner G, Lohr KN, Griffith D, Rhodes S, Samuel-Hodge C, Matry S, Lux L, Webb L, Sutton SF, Swinson T, Jackman A, Whitener L. 2004. Community-Based Participatory Research: Assessing the Evidence. AHRQ Publication 04-E022-1. Rockville, MD: Agency for Healthcare Research and Quality.